Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE
SELECT-COMPARE 研究:类风湿性关节炎患者从 Upadacitinib 转换为 Adalimumab 治疗后的长期疗效和安全性:5 年数据
期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00658-1
Fleischmann, Roy; Blanco, Ricardo; Van den Bosch, Filip; Bessette, Louis; Song, Yanna; Penn, Sara K; McDearmon-Blondell, Erin; Khan, Nasser; Chan, Kelly; Mysler, Eduardo